ATS Gives Smith & Nephew Second Skin; Wound Treatment Portfolio Elevated
This article was originally published in The Gray Sheet
Executive Summary
Smith & Nephew's joint venture with Advanced Tissue Sciences to develop and market Dermagraft bio-engineered skin will be a major driver of S&N growth over the next five years, the British firm anticipates